SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 2, 2010 PRIMARY DOCUMENT
4 Jul 2, 2010 PRIMARY DOCUMENT
8-K Jun 10, 2010 FORM 8-K
EFFECT May 28, 2010
EFFECT May 28, 2010
S-3 May 24, 2010 RXI PHARMACEUTICALS CORPORATION
S-3 May 21, 2010 RXI PHARMACEUTICALS CORPORATION
8-K May 18, 2010 FORM 8-K
10-Q May 17, 2010 RXI PHARMACEUTICALS CORPORATION
ARS Apr 28, 2010 AUTO-GENERATED PAPER DOCUMENT
DEFA14A Apr 23, 2010 DEFA14A
DEF 14A Apr 23, 2010 DEF 14A
4 Apr 16, 2010 FORM 4 SUBMISSION
4 Apr 16, 2010 FORM 4 SUBMISSION
4 Apr 16, 2010 FORM 4 SUBMISSION
4 Apr 16, 2010 FORM 4 SUBMISSION
4 Apr 2, 2010 FORM 4 SUBMISSION
10-K Mar 31, 2010 FORM 10-K
8-K Mar 31, 2010 FORM 8-K
4 Mar 30, 2010 FORM 4 SUBMISSION
4 Mar 30, 2010 FORM 4 SUBMISSION
424B5 Mar 23, 2010 RXI PHARMACEUTICALS CORPORATION
FWP Mar 23, 2010 RXI PHARMACEUTICALS CORPORATION
8-K Mar 23, 2010 RXI PHARMACEUTICALS CORPORATION
S-3MEF Mar 22, 2010 RXI PHARMACEUTICALS CORPORATION
← Newer Page 43 of 51 · 1272 filings Older →